Could microdosing PT-141 (bremelanotide) deliver better libido results than standard doses? Many men find that typical PT-141 doses (500mcg-2mg) produce disappointing or inconsistent effects on libido—but a different dosing strategy involving multiple small daily doses may unlock dramatically better results by better mimicking natural α-MSH physiology.
This detailed discussion documents a protocol using 15-20mcg of bremelanotide injected 5 times throughout the day, which produced high sustained libido and easy erections—far superior to single large doses. We discuss the science behind why standard PT-141 dosing may be "overdosing" relative to natural hormone levels, optimal protocols, tolerance/reset periods, and how this approach compares to on-demand use for sexual enhancement.
---------------------
TL;DR: It may be possible to improve results with bremelanotide by taking multiple daily micro-doses.
Like many, I have experimented with bremelanotide at the recommended doses, which range from a few hundred micrograms up to a couple milligrams in one subcutaneous injection. And also like many, I found the results to be disappointing. Libido was not affected, spontaneous erections during the day were infrequent and random, and nighttime erections were prominent and disturbed sleep. Although the effects were not as desired, they seemed quite strong, leading me to question how bremelanotide compares to α-melanocyte-stimulating hormone, aka α-MSH, the hormone it augments. Some rudimentary calculations suggest that standard doses of bremelanotide could be comparable to an increase in α-MSH by as much as two orders of magnitude. That’s somewhat like giving a hypogonadal male 100 mg of testosterone propionate every couple weeks. He may experience some interesting effects, but there’s still some likelihood the overall experience would be poor, and certainly not comparable to TRT.
Credit to @Guided_by_Voices for also experimenting with and recommending lower doses of bremelanotide. I suspect these doses of 100-300 mcg could still be large relative to normal physiology — having very roughly estimated that multiple small daily doses on the order of 10 mcg would provide stimulation comparable to endogenous α-MSH. I set about testing this premise as follows:
Phase 1, days 1-4
Protocol: 20 mcg bremelanotide injected SC at 6 am, 9 am, 12 pm, 3 pm and 6 pm.
Results: Compared to a lackadaisical baseline, libido was high, even excessive and distracting. This began on the first day and continued for the entire phase. The “itch” was nearly constant, and erections came easily in response to sexual ideation or the presence of nubile females. This was again in marked contrast to baseline, where daytime erections were very uncommon without more substantial stimulation. The two negatives during this phase were a reduction in average sleep duration by 30-40 minutes and a slight feeling of overstimulation throughout. In fact these led to a dose reduction and the second phase. This was unfortunate from a data-gathering standpoint, because if the first phase was part of a honeymoon period then the period’s full duration was not established.
Phase 2, days 5-8
Protocol: 10 mcg bremelanotide injected SC at 6 am, 9 am, 12 pm, 3 pm and 6 pm.
Results: There was a rapid return to near-baseline conditions, though sleep still seemed degraded.
Phase 3, days 9-12
Protocol: 15 mcg bremelanotide injected SC at 6 am, 9 am, 12 pm, 3 pm and 6 pm.
Results: Libido improved a small amount. There was improvement in spontaneity of erections, but nothing like during the first phase. Sleep was modestly impaired compared to baseline.
Phase 4, days 13-15
Protocol: 20 mcg bremelanotide injected SC at 6 am, 9 am, 12 pm, 3 pm and 6 pm.
Results: This was an attempt to see if the results of the first phase would reappear after the prolonged exposure to slightly lower doses. They did not. Over these three days libido and sexual function dropped below baseline. Modest sleep impairment continued.
Phase 5, days 16-17
Protocol: no bremelanotide
Results: After this washout period things seemed to return to baseline.
Discussion: These results point to the need for further research. It’s intriguing to consider that it may be possible to obtain much better results with bremelanotide when it is dosed appropriately. While multiple daily injections are going to be unappealing to most, it seems likely that these protocols could be reproduced with correctly dosed troches and buccal delivery. It looks as though four days of the initial protocol was nearing the end of a possible honeymoon period, with most benefits dissipating soon thereafter. If so then the appropriate reset period is yet to be determined. If this period is only a week or two then the protocol is promising. My sense is that even 20 mcg taken five times a day is a pretty high level of stimulation relative to baseline α-MSH activity — thus caution is advised if long-term use is contemplated. It is concerning that prolonged continuous use in this trial seemed to degrade libido and sexual function below baseline, though at least recovery was rapid.
I continue to speculate that this is not the only case where overdosing a peptide obscures its full potential. For example, long-term micro-dosing of oxytocin may yield profound results that are dissimilar to what’s seen with occasional administration of much higher doses.
More experiences with PT-141
ExcelMale - #1 TRT & Testosterone Forum | Expert-Moderated Men's Health Community
Erection Effects — The Strongest Signal
The most consistent finding across members is a powerful effect on erections, though timing is unpredictable.
One member documented dose-dependent onset timing at 1.5–2 mg range:
Libido — Inconsistent, Dose- and Person-Dependent
Results on desire vary widely. Some members report no libido effect at all — erections appear but desire is unchanged. Others describe it as transformative for both ED and libido, particularly in combination with PDE5 inhibitors.
One member noted tachyphylaxis (diminishing returns) with frequent use:
Settled protocol for that member: 2x/week maximum to preserve response.
Special Population: Post-Finasteride Syndrome (PFS)
PT-141 has shown some of its most striking results in men with neurogenic or psychogenic sexual dysfunction — especially PFS — where conventional therapies have failed.
Note: The ExcelMale PFS thread is one of the most instructive resources on PT-141 for men with treatment-resistant sexual dysfunction. Members with neurogenic or psychogenic components report meaningful responses where PDE5 inhibitors and TRT optimization alone did not produce results.
Microdosing Protocol — Member Cataceous (Sept. 2023)
Background: Standard PT-141 doses (500 mcg–2 mg) may represent massive overstimulation relative to endogenous alpha-MSH levels. Member Cataceous calculated this as analogous to giving a hypogonadal man 100 mg of testosterone propionate instead of physiologic replacement.
Protocol: 15–20 mcg injected 5 times daily
Results — First 4 Days:
Limitations:
Caution: One member reported a severe anhedonia episode from PT-141 at just 200 mcg in 2018, with symptoms resembling PSSD/PFS. He attributed long-term neurological sensitization to that single use. This appears rare but is documented in the thread.
Side Effects — The Primary Barrier
Community tip on managing nausea:
Dosing Reference — What Members Report
Injection route note: One member found IM injections kick in faster than SubQ but do not last as long — difference is not dramatic but may matter for timing sex.
PT-141 vs. Trimix — The Recurring Comparison
Combination Approaches Members Use
Community Bottom Line
PT-141 is a legitimate tool — particularly for men who have optimized TRT and E2 and still struggle with low desire or neurogenic ED. But it behaves more like a pharmacological experiment than a reliable on-demand product.
This detailed discussion documents a protocol using 15-20mcg of bremelanotide injected 5 times throughout the day, which produced high sustained libido and easy erections—far superior to single large doses. We discuss the science behind why standard PT-141 dosing may be "overdosing" relative to natural hormone levels, optimal protocols, tolerance/reset periods, and how this approach compares to on-demand use for sexual enhancement.
---------------------
TL;DR: It may be possible to improve results with bremelanotide by taking multiple daily micro-doses.
Like many, I have experimented with bremelanotide at the recommended doses, which range from a few hundred micrograms up to a couple milligrams in one subcutaneous injection. And also like many, I found the results to be disappointing. Libido was not affected, spontaneous erections during the day were infrequent and random, and nighttime erections were prominent and disturbed sleep. Although the effects were not as desired, they seemed quite strong, leading me to question how bremelanotide compares to α-melanocyte-stimulating hormone, aka α-MSH, the hormone it augments. Some rudimentary calculations suggest that standard doses of bremelanotide could be comparable to an increase in α-MSH by as much as two orders of magnitude. That’s somewhat like giving a hypogonadal male 100 mg of testosterone propionate every couple weeks. He may experience some interesting effects, but there’s still some likelihood the overall experience would be poor, and certainly not comparable to TRT.
Credit to @Guided_by_Voices for also experimenting with and recommending lower doses of bremelanotide. I suspect these doses of 100-300 mcg could still be large relative to normal physiology — having very roughly estimated that multiple small daily doses on the order of 10 mcg would provide stimulation comparable to endogenous α-MSH. I set about testing this premise as follows:
Phase 1, days 1-4
Protocol: 20 mcg bremelanotide injected SC at 6 am, 9 am, 12 pm, 3 pm and 6 pm.
Results: Compared to a lackadaisical baseline, libido was high, even excessive and distracting. This began on the first day and continued for the entire phase. The “itch” was nearly constant, and erections came easily in response to sexual ideation or the presence of nubile females. This was again in marked contrast to baseline, where daytime erections were very uncommon without more substantial stimulation. The two negatives during this phase were a reduction in average sleep duration by 30-40 minutes and a slight feeling of overstimulation throughout. In fact these led to a dose reduction and the second phase. This was unfortunate from a data-gathering standpoint, because if the first phase was part of a honeymoon period then the period’s full duration was not established.
Phase 2, days 5-8
Protocol: 10 mcg bremelanotide injected SC at 6 am, 9 am, 12 pm, 3 pm and 6 pm.
Results: There was a rapid return to near-baseline conditions, though sleep still seemed degraded.
Phase 3, days 9-12
Protocol: 15 mcg bremelanotide injected SC at 6 am, 9 am, 12 pm, 3 pm and 6 pm.
Results: Libido improved a small amount. There was improvement in spontaneity of erections, but nothing like during the first phase. Sleep was modestly impaired compared to baseline.
Phase 4, days 13-15
Protocol: 20 mcg bremelanotide injected SC at 6 am, 9 am, 12 pm, 3 pm and 6 pm.
Results: This was an attempt to see if the results of the first phase would reappear after the prolonged exposure to slightly lower doses. They did not. Over these three days libido and sexual function dropped below baseline. Modest sleep impairment continued.
Phase 5, days 16-17
Protocol: no bremelanotide
Results: After this washout period things seemed to return to baseline.
Discussion: These results point to the need for further research. It’s intriguing to consider that it may be possible to obtain much better results with bremelanotide when it is dosed appropriately. While multiple daily injections are going to be unappealing to most, it seems likely that these protocols could be reproduced with correctly dosed troches and buccal delivery. It looks as though four days of the initial protocol was nearing the end of a possible honeymoon period, with most benefits dissipating soon thereafter. If so then the appropriate reset period is yet to be determined. If this period is only a week or two then the protocol is promising. My sense is that even 20 mcg taken five times a day is a pretty high level of stimulation relative to baseline α-MSH activity — thus caution is advised if long-term use is contemplated. It is concerning that prolonged continuous use in this trial seemed to degrade libido and sexual function below baseline, though at least recovery was rapid.
I continue to speculate that this is not the only case where overdosing a peptide obscures its full potential. For example, long-term micro-dosing of oxytocin may yield profound results that are dissimilar to what’s seen with occasional administration of much higher doses.
More experiences with PT-141
ExcelMale - #1 TRT & Testosterone Forum | Expert-Moderated Men's Health Community
ExcelMale Member Experiences: PT-141 (Bremelanotide)
Compiled from ExcelMale forum threads | Updated June 2026
Compiled from ExcelMale forum threads | Updated June 2026
Erection Effects — The Strongest Signal
The most consistent finding across members is a powerful effect on erections, though timing is unpredictable.
One member documented dose-dependent onset timing at 1.5–2 mg range:
- 1 mg — Onset 8+ hours
- 1.5 mg — Onset 4–6 hours; spontaneous erections lasting 24–36 hours including nighttime
- 2 mg — Onset 3–4 hours; doses above 2 mg triggered severe nausea
Libido — Inconsistent, Dose- and Person-Dependent
Results on desire vary widely. Some members report no libido effect at all — erections appear but desire is unchanged. Others describe it as transformative for both ED and libido, particularly in combination with PDE5 inhibitors.
One member noted tachyphylaxis (diminishing returns) with frequent use:
Settled protocol for that member: 2x/week maximum to preserve response.
Special Population: Post-Finasteride Syndrome (PFS)
PT-141 has shown some of its most striking results in men with neurogenic or psychogenic sexual dysfunction — especially PFS — where conventional therapies have failed.
Note: The ExcelMale PFS thread is one of the most instructive resources on PT-141 for men with treatment-resistant sexual dysfunction. Members with neurogenic or psychogenic components report meaningful responses where PDE5 inhibitors and TRT optimization alone did not produce results.
Microdosing Protocol — Member Cataceous (Sept. 2023)
Background: Standard PT-141 doses (500 mcg–2 mg) may represent massive overstimulation relative to endogenous alpha-MSH levels. Member Cataceous calculated this as analogous to giving a hypogonadal man 100 mg of testosterone propionate instead of physiologic replacement.
Protocol: 15–20 mcg injected 5 times daily
- 6:00 AM
- 9:00 AM
- 12:00 PM
- 3:00 PM
- 6:00 PM
Results — First 4 Days:
- Sustained high libido throughout the day
- Easy erections with minimal stimulation
- Qualitatively described as far superior to single large-dose use
Limitations:
- Rapid honeymoon effect — response diminished quickly after the first few days
- Sleep disruption — average 30–40 minute reduction per night
- Paradoxical libido drop below baseline with prolonged continuous use
- Requires 5 injections per day — impractical for most men
Caution: One member reported a severe anhedonia episode from PT-141 at just 200 mcg in 2018, with symptoms resembling PSSD/PFS. He attributed long-term neurological sensitization to that single use. This appears rare but is documented in the thread.
Side Effects — The Primary Barrier
| Side Effect | Frequency | Notes |
|---|---|---|
| Nausea | Most common | Can be severe and delayed; Zofran prescribed by some doctors; eating before dosing helps |
| Facial flushing | Common | Resolves within 2–4 hours; typically diminishes with repeated use |
| Body aches / feeling cold | Common | Reported as 8–9 hours duration; consistent with systemic melanocortin effects |
| Headache | Moderate | Typically mild and self-limiting |
| Blood pressure elevation | Clinical data | Mean +2 mmHg systolic/diastolic; ~1% of patients reach 180/110 mmHg or higher |
| Low mood | Some members | Reported as 8–9 hours post-injection; not universal |
| Sinus congestion | Some members | Particularly problematic for those with seasonal allergies |
| Sleep disruption | Microdose protocol | 30–40 min reduction per night; due to spontaneous nighttime erections |
Community tip on managing nausea:
Dosing Reference — What Members Report
| Dose Range | Typical Outcome |
|---|---|
| 125–200 mcg | Minimal to no effects; recommended acclimation starting point |
| 500 mcg – 1 mg | Some libido/erection effects; slower onset (~8 hrs) |
| 1.5 – 2 mg | Most members' sweet spot; 3–6 hr onset; nausea risk begins here |
| 2.5 – 3 mg | Stronger effects; higher nausea risk; one member's documented sweet spot |
| 3+ mg | Effective for some but significant side effect burden |
| 15–20 mcg × 5/day | Microdosing protocol; strong first 4 days; then tolerance develops |
Injection route note: One member found IM injections kick in faster than SubQ but do not last as long — difference is not dramatic but may matter for timing sex.
PT-141 vs. Trimix — The Recurring Comparison
| PT-141 | Trimix | |
|---|---|---|
| Onset | 45 min – 8 hrs (dose-dependent) | 5–10 minutes |
| Reliability | Unpredictable timing | Highly reliable |
| Erection quality | Described as more "sexual" in feel | Strong but mechanical |
| Libido effect | Variable — present for some | None directly |
| Side effects | Nausea, flushing, aches | Priapism risk; injection site |
Combination Approaches Members Use
- PT-141 + Viagra or Cialis — Most commonly mentioned combination; described as synergistic. One member called PT-141 + Viagra + cock ring "transformative."
- PT-141 + Melanotan-2 — Several members use MT-2 in winter (for libido + tanning) and PT-141 in summer (to avoid excessive tanning).
- PT-141 + Trimix — Logical combination for men with both desire/arousal and vascular ED components; works on separate systems. Limited community data but discussed positively.
Community Bottom Line
PT-141 is a legitimate tool — particularly for men who have optimized TRT and E2 and still struggle with low desire or neurogenic ED. But it behaves more like a pharmacological experiment than a reliable on-demand product.
- Responses are highly individual — the same dose produces wildly different outcomes across members
- Timing is unpredictable — it is not a 30-minute Viagra equivalent
- Side effects can be significant — start low and titrate
- Tolerance develops — limit use to 1–2x per week maximum; build in rest periods
- Best candidate: Men whose primary difficulty is the desire or arousal component, not pure vascular ED
- Combination protocols often outperform PT-141 alone
This compilation draws from ExcelMale.com member threads. Individual experiences vary. PT-141 is FDA-approved for premenopausal women with HSDD only; use in men is off-label. Consult your physician before starting any peptide therapy.
Last edited by a moderator:
